GBp 7.25
(0.0%)
Breakdown | 2023 | 2022 |
---|---|---|
Revenue | - | - |
Cost of Revenue | 10.73 Thousand | - |
Gross Profit | -10.73 Thousand | - |
Operating Expenses | 547.87 Thousand | 102.71 Thousand |
Selling, General and Administrative Expenses | 545.61 Thousand | 102.71 Thousand |
Research and Development Expenses | - | - |
Other Expenses | - | - |
Cost and Expenses | 558.61 Thousand | 102.71 Thousand |
Operating Income | -664.94 Thousand | -103.16 Thousand |
Interest Expense | 43.94 Thousand | 19.91 Thousand |
Income Tax Expense | - | - |
Earnings before Tax | -708.88 Thousand | -123.08 Thousand |
Net Income | -708.88 Thousand | -123.08 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 144.49 Million | 144.49 Million |
Weighted Average Shares Outstanding (Diluted) | 144.49 Million | 144.49 Million |
Gross Margin | - | - |
EBIT Margin | - | - |
Profit Margin | - | - |
EBITDA | -573.51 Thousand | -103.16 Thousand |
Earnings Before Tax Margin | - | - |
Breakdown | 2023 FY | 2022 FY |
---|---|---|
Revenue | - | - |
Cost of Revenue | 10.73 Thousand | - |
Gross Profit | -10.73 Thousand | - |
Operating Expenses | 547.87 Thousand | 102.71 Thousand |
Selling, General and Administrative Expenses | - | - |
Research and Development Expenses | - | - |
Other Expenses | - | - |
Cost and Expenses | 558.61 Thousand | 102.71 Thousand |
Operating Income | -664.94 Thousand | -103.16 Thousand |
Interest Expense | 43.94 Thousand | 19.91 Thousand |
Income Tax Expense | - | - |
Earnings before Tax | -708.88 Thousand | -123.08 Thousand |
Net Income | -708.88 Thousand | -123.08 Thousand |
Earnings Per Share Basic | - | - |
Earnings Per Share Diluted | - | - |
Weighted Average Shares Outstanding | 144.49 Million | 144.49 Million |
Weighted Average Shares Outstanding (Diluted) | 144.49 Million | 144.49 Million |
Gross Margin | - | - |
EBIT Margin | - | - |
Profit Margin | - | - |
EBITDA | - | - |
Earnings Before Tax Margin | - | - |
0HHP
SASTASUNDR
NYMTM
HBSA3
NO4
LASTMILE